Respiratory
GSK Ireland information about our respiratory portfolio, as well as resources and latest news.
Not a healthcare professional? Visit our Public site
Not a healthcare professional? Visit our Public site
GSK's primary therapy areas
POM. Further information is available from GlaxoSmithKline (Ireland) Ltd
Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: www.hpra.ie. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255 or via online form https://gsk.public.reportum.com.
PM-IE-NA-WCNT-240001 | August 2025